Clinical Trials Related to Hepatocellular Carcinoma

Related studies linked through entity extraction aliases.

Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma

Status: UNKNOWN
Phase: PHASE1/PHASE2

A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)

Status: COMPLETED
Phase: PHASE2

Searching for the Liver Cancer-Related Biomarkers

Status: UNKNOWN
Phase: N/A

Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI

Status: UNKNOWN
Phase: N/A

Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer

Status: TERMINATED
Phase: PHASE2/PHASE3

Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma

Status: COMPLETED
Phase: PHASE3

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

Status: COMPLETED
Phase: PHASE2

Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma

Status: COMPLETED
Phase: PHASE2

Adult-to-Adult Living Donor Liver Transplantation Study

Status: COMPLETED
Phase: N/A

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Status: COMPLETED
Phase: PHASE1/PHASE2

Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma

Status: COMPLETED
Phase: PHASE1/PHASE2

Prevention of Recurrent Hepatitis B After Liver Transplantation

Status: COMPLETED
Phase: N/A

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Status: UNKNOWN
Phase: PHASE1/PHASE2

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Status: TERMINATED
Phase: PHASE2/PHASE3

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads

Status: UNKNOWN
Phase: PHASE1/PHASE2

Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.

Status: UNKNOWN
Phase: PHASE2